Who are the key players in Sulfonylureas Market?

Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma and Dr. Reddy's Laboratories are the major companies operating in the Sulfonylureas Market. Read More

Which is the fastest growing region in Sulfonylureas Market?

Middle East and Africa is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Sulfonylureas Market?

In 2024, the North America accounts for the largest market share in Sulfonylureas Market. Read More

What years does this Sulfonylureas Market cover, and what was the market size in 2023?

In 2023, the Sulfonylureas Market size was estimated at USD 9.67 billion. The report covers the Sulfonylureas Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Sulfonylureas Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Sulfonylureas Market Size

Market Size of Sulfonylureas Industry

Study Period	2019- 2029
Market Size (2024)	USD 9.98 Billion
Market Size (2029)	USD 11.32 Billion
CAGR (2024 - 2029)	3.12 %
Fastest Growing Market	Middle East and Africa
Largest Market	North America
Major Players *Disclaimer: Major Players sorted in no particular order

Sulfonylureas Market Analysis

The Sulfonylureas Market size is estimated at USD 9.98 billion in 2024, and is expected to reach USD 11.32 billion by 2029, growing at a CAGR of 3.12% during the forecast period (2024-2029).

The COVID-19 pandemic has had a substantial impact on the Sulfonylureas market. The prevalence of diabetes in people hospitalized with COVID-19 infection and the recognition that improved glycemic control might improve outcomes and reduce the length of stay in patients with SARS-CoV-2 have underlined the importance of the oral anti-diabetic drugs market. People with diabetes have a weaker immune system, the COVID-19 complication aggravates the condition, and the immune system gets weaker very fast. Diabetes and uncontrolled hyperglycemia are risk factors for poor outcomes in patients with COVID-19 including an increased risk of severe illness or death. Thus, the COVID-19 outbreak increased the sulfonylureas market's growth globally.

Sulfonylurea is an oral anti-diabetic drug used to treat type 2 diabetes. People with type 2 diabetes have chronically high blood sugar levels and sulfonylureas make the body free up more insulin.

In May 2021, the World Health Assembly agreed on a Resolution on strengthening the prevention and control of diabetes. It recommends action in areas including increasing access to medicines and health products for the treatment of diabetes and assessing the feasibility and potential value of establishing a web-based tool to share information relevant to the transparency of markets for diabetes medicines and health products.

According to International Diabetes Federation (IDF), the adult diabetes population in 2021 is approximately 537 million, and this number is going to increase by 643 million in 2030. The rate of newly diagnosed cases of Type 1 and Type 2 diabetes is seen to increase, mainly due to obesity, unhealthy diet, and physical inactivity. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure worldwide are indications of the increasing usage of anti-diabetic drugs. Technological advancements and innovations have increased over the period leading to several modifications either in the drugs or the formulations being developed.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

Sulfonylureas Industry Segmentation

The sulfonylureas are a class of agents that lower blood sugar by increasing the release of insulin from the pancreas. The Sulfonylureas Market is segmented into geography (North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America). The report offers the value (in USD) and volume (in units) for the above segments.

Geography

North America
	United States
	Canada
	Rest of North America

Europe
	France
	Germany
	Italy
	Spain
	United Kingdom
	Russia
	Rest of Europe

Latin America
	Mexico
	Brazil
	Rest of Latin America

Asia-Pacific
	Japan
	South Korea
	China
	India
	Australia
	Vietnam
	Malaysia
	Indonesia
	Philippines
	Thailand
	Rest of Asia-Pacific

Middle East and Africa
	Saudi Arabia
	Iran
	Egypt
	Oman
	South Africa
	Rest of Middle East and Africa

Need A Different Region Or Segment?

Customize Now

Sulfonylureas Market Size Summary

The sulfonylureas market is poised for growth, driven by the increasing prevalence of type 2 diabetes and the rising demand for effective oral anti-diabetic medications. Sulfonylureas play a crucial role in managing blood sugar levels by stimulating insulin release from pancreatic beta cells, making them a vital component in diabetes care, especially after the initial treatment with metformin. The market's expansion is further supported by global health initiatives, such as the World Health Assembly's resolution on diabetes prevention and control, and the WHO's Global Diabetes Compact, which aim to enhance access to diabetes treatments and improve care standards worldwide. The COVID-19 pandemic has also underscored the importance of glycemic control, as diabetes patients face heightened risks, thereby boosting the demand for sulfonylureas.

Regionally, the Middle East and Africa are expected to experience significant market growth due to alarming increases in diabetes prevalence, driven by lifestyle changes and obesity. Governments in these regions are actively implementing policies to improve healthcare access and affordability, which is anticipated to further stimulate market growth. The sulfonylureas market is characterized by fragmentation, with major players like Pfizer, Sanofi, and Merck holding substantial market shares alongside numerous generic manufacturers. Regulatory developments, such as pricing controls and safety warnings, also influence market dynamics, ensuring that sulfonylureas remain a critical component of diabetes management strategies globally.

Explore More

Sulfonylureas Market Size - Table of Contents

1. MARKET DYNAMICS
1. 1.1 Market Overview
2. 1.2 Market Drivers
3. 1.3 Market Restraints
4. 1.4 Porter's Five Forces Analysis
  1. 1.4.1 Bargaining Power of Suppliers
  2. 1.4.2 Bargaining Power of Consumers
  3. 1.4.3 Threat of New Entrants
  4. 1.4.4 Threat of Substitute Products and Services
  5. 1.4.5 Intensity of Competitive Rivalry
2. MARKET SEGMENTATION
1. 2.1 Sulphonylureas
2. 2.2 Geography
  1. 2.2.1 North America
    1. 2.2.1.1 United States
    2. 2.2.1.2 Canada
    3. 2.2.1.3 Rest of North America
  2. 2.2.2 Europe
    1. 2.2.2.1 France
    2. 2.2.2.2 Germany
    3. 2.2.2.3 Italy
    4. 2.2.2.4 Spain
    5. 2.2.2.5 United Kingdom
    6. 2.2.2.6 Russia
    7. 2.2.2.7 Rest of Europe
  3. 2.2.3 Latin America
    1. 2.2.3.1 Mexico
    2. 2.2.3.2 Brazil
    3. 2.2.3.3 Rest of Latin America
  4. 2.2.4 Asia-Pacific
    1. 2.2.4.1 Japan
    2. 2.2.4.2 South Korea
    3. 2.2.4.3 China
    4. 2.2.4.4 India
    5. 2.2.4.5 Australia
    6. 2.2.4.6 Vietnam
    7. 2.2.4.7 Malaysia
    8. 2.2.4.8 Indonesia
    9. 2.2.4.9 Philippines
    10. 2.2.4.10 Thailand
    11. 2.2.4.11 Rest of Asia-Pacific
  5. 2.2.5 Middle East and Africa
    1. 2.2.5.1 Saudi Arabia
    2. 2.2.5.2 Iran
    3. 2.2.5.3 Egypt
    4. 2.2.5.4 Oman
    5. 2.2.5.5 South Africa
    6. 2.2.5.6 Rest of Middle East and Africa